ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,842, issued on Sept. 16, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).
"Immunostimulating IL-2 analogs" was invented by Euh Lim Oh (Hwaseong-si, South Korea), Sang Yun Kim (Hwaseong-si, South Korea), Yong Ho Heo (Hwaseong-si, South Korea), Jin Young Kim (Hwaseong-si, South Korea), Cho Rong Park (Hwaseong-si, South Korea), Jun Sub Park (Hwaseong-si, South Korea) and Hyun Soo Ryu (Hwaseong-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "Modifications to interleukin-2 alpha receptors are disclosed. Interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors are disclosed."
The patent was f...